E-LIB Suche - Ergebnisse für: Iida, Harunobu

1

Low-dose rituximab as induction therapy for ANCA-associated..:

Takakuwa, Yukiko ; Hanaoka, Hironari ; Kiyokawa, Tomofumi...
Clinical Rheumatology. 38 (2019) 4 - p. 1217-1223 , 2019

Link: https://doi.org/10.1007/..

2

Glucocorticoid, immunosuppressant, hydroxychloroquine monot..:

Hanaoka, Hironari ; Iida, Harunobu ; Kiyokawa, Tomofumi..
Clinical Rheumatology. 38 (2019) 10 - p. 2785-2791 , 2019

Link: https://doi.org/10.1007/..

3

A low perfusion‐metabolic mismatch in 99mTl and 123I‐BMIPP ..:

Iida, Harunobu ; Hanaoka, Hironari ; Okada, Yukinori...
International Journal of Rheumatic Diseases. 22 (2019) 6 - p. 1008-1015 , 2019

Link: https://doi.org/10.1111/..

4

Hydroxychloroquine Improves the Disease Activity and Allows..:

Hanaoka, Hironari ; Iida, Harunobu ; Kiyokawa, Tomofumi..
Internal Medicine. 58 (2019) 9 - p. 1257-1262 , 2019

Link: https://doi.org/10.2169/..

5

Rhabdomyolysis in a Patient with Polyarteritis Nodosa:

Iida, Harunobu ; Hanaoka, Hironari ; Asari, Yusa...
Internal Medicine. 57 (2018) 1 - p. 101-106 , 2018

Link: https://doi.org/10.2169/..

6

Low additive effect of hydroxychloroquine on Japanese patie..:

Hanaoka, Hironari ; Iida, Harunobu ; Kiyokawa, Tomofumi..
International Journal of Rheumatic Diseases. 22 (2018) 3 - p. 468-472 , 2018

Link: https://doi.org/10.1111/..

7

Renal protective effect of antiplatelet therapy in antiphos..:

Hanaoka, Hironari ; Iida, Harunobu ; Kiyokawa, Tomofumi...
PLOS ONE. 13 (2018) 5 - p. e0196172 , 2018

Link: https://doi.org/10.1371/..

8

Mycophenolate mofetil treatment with or without a calcineur..:

Hanaoka, Hironari ; Iida, Harunobu ; Kiyokawa, Tomofumi..
Clinical Rheumatology. 38 (2018) 2 - p. 585-590 , 2018

Link: https://doi.org/10.1007/..

9

Early achievement of deep remission predicts low incidence ..:

Hanaoka, Hironari ; Iida, Harunobu ; Kiyokawa, Tomofumi..
Arthritis Research & Therapy. 20 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

10

Comparison of renal response to four different induction th..:

Hanaoka, Hironari ; Kiyokawa, Tomofumi ; Iida, Harunobu...
PLOS ONE. 12 (2017) 4 - p. e0175152 , 2017

Link: https://doi.org/10.1371/..

11

Lack of partial renal response by 12 weeks after induction ..:

Hanaoka, Hironari ; Yamada, Hidehiro ; Kiyokawa, Tomofumi...
Arthritis Research & Therapy. 19 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

12

Hydroxychloroquine Improves the Disease Activity and Allows..:

Hanaoka, Hironari ; Iida, Harunobu ; Kiyokawa, Tomofumi..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543229/. , 2019

Link: http://www.ncbi.nlm.nih...

13

Renal protective effect of antiplatelet therapy in antiphos..:

Hanaoka, Hironari ; Iida, Harunobu ; Kiyokawa, Tomofumi...
https://repository.publisso.de/resource/frl:6453339. , 2018

Link: https://repository.publi..

14

Rhabdomyolysis in a Patient with Polyarteritis Nodosa:

Iida, Harunobu ; Hanaoka, Hironari ; Asari, Yusa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799066/. , 2017

Link: http://www.ncbi.nlm.nih...

15

Early achievement of deep remission predicts low incidence ..:

Hironari Hanaoka ; Harunobu Iida ; Tomofumi Kiyokawa..
http://link.springer.com/article/10.1186/s13075-018-1576-1. , 2018

Link: https://doi.org/10.1186/..